EXAS
NASDAQ · Biotechnology
Exact Sciences Corp
$104.91
+0.99 (+0.95%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+3.29%
1Y
+99.68%
YTD
+3.12%
Open$104.93
Previous Close$103.92
Day High$104.98
Day Low$104.90
52W High$104.98
52W Low$38.81
Volume—
Avg Volume4.06M
Market Cap20.03B
P/E Ratio—
EPS$-1.10
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$102.19
Above
SMA 200
$69.24
Above
RSI (14)
74.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
29 analysts
Price Target
+24.6% upside
Current
$104.91
$104.91
Target
$130.71
$130.71
$80.73
$130.71 avg
$205.54
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.28B | 2.83B | 5.75B |
| Net Income | -210,377,895 | -163,336,875 | -895,146,132 |
| Profit Margin | -6.4% | -6.1% | -15.6% |
| EBITDA | -82,368,262 | -67,503,320 | -1,423,315,581 |
| Free Cash Flow | — | — | -873,819,141 |
| Rev Growth | +15.9% | +15.9% | -4.7% |
| Debt/Equity | 0.97 | 0.97 | 0.09 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |